- Видео 1 151
- Просмотров 2 790 697
BioStock
Швеция
Добавлен 20 янв 2017
BioStock är Skandinaviens ledande digitala nyhets- och analystjänst med exklusivt fokus på bolag i Life Science-sektorn. Redaktionen är placerad på Medicon Village i Lund som är ett av Sveriges främsta innovationskluster för life science-bolag.
BioStocks innehåll riktar sig till investerare samt representanter för bolag och organisationer inom bioteknik, medicinteknik, diagnostik och läkemedelsutveckling. BioStocks dagliga nyhetsuppdateringar följs av en majoritet av beslutsfattare på ledningsnivå inom nordisk life science.
Genom att distribuera BioStocks nyheter, artiklar och intervjuer samt filmade investerarevent och kapitalmarknadsdagar parallellt i ett flertal kanaler samt via ett brett nätverk av mediapartners når BioStocks innehåll en bred bas av industriledare och investerare, såväl i Sverige som internationellt.
Allt innehåll som publiceras på BioStock kan och får delas förutsatt att hänvisning ges till källan, med undantag för tredje parts kommersiella syften.
BioStocks innehåll riktar sig till investerare samt representanter för bolag och organisationer inom bioteknik, medicinteknik, diagnostik och läkemedelsutveckling. BioStocks dagliga nyhetsuppdateringar följs av en majoritet av beslutsfattare på ledningsnivå inom nordisk life science.
Genom att distribuera BioStocks nyheter, artiklar och intervjuer samt filmade investerarevent och kapitalmarknadsdagar parallellt i ett flertal kanaler samt via ett brett nätverk av mediapartners når BioStocks innehåll en bred bas av industriledare och investerare, såväl i Sverige som internationellt.
Allt innehåll som publiceras på BioStock kan och får delas förutsatt att hänvisning ges till källan, med undantag för tredje parts kommersiella syften.
BioStock Life Science Summit 2024 – Day 2 Part 1
At the seventh annual BioStock Life Science Summit, 30+ life science companies showcase their projects and business cases to investors potential partners. The event also offer thought-provoking insights from industry leaders and expert investors. The Summit is attended by significant players in the life science ecosystem.
The Summit connects innovation and capital, providing small-to-medium cap Nordic companies from a wide range of therapeutic areas the platform and opportunity to make their case to both Swedish and international investors as well as top-level poteThntial partners in a unique boutique setting.
A diverse array of company presentations and pitches will showcase the exception...
The Summit connects innovation and capital, providing small-to-medium cap Nordic companies from a wide range of therapeutic areas the platform and opportunity to make their case to both Swedish and international investors as well as top-level poteThntial partners in a unique boutique setting.
A diverse array of company presentations and pitches will showcase the exception...
Просмотров: 0
Видео
BioStock Life Science Summit - Day 2 Part 2
Просмотров 12 часа назад
At the seventh annual BioStock Life Science Summit, 30 life science companies showcase their projects and business cases to investors potential partners. The event also offer thought-provoking insights from industry leaders and expert investors. The Summit is attended by significant players in the life science ecosystem. The Summit connects innovation and capital, providing small-to-medium cap ...
BioStock Life Science Summit 2024 - Day 1 Part 2
Просмотров 3282 часа назад
At the seventh annual BioStock Life Science Summit, 30 life science companies showcase their projects and business cases to investors and potential partners. The event also offer thought-provoking insights from industry leaders and expert investors. The Summit is attended by significant players in the life science ecosystem. The Summit connects innovation and capital, providing small-to-medium ...
BioStock Life Science Summit 2024 - Day 1 Part 1
Просмотров 3092 часа назад
At the seventh annual BioStock Life Science Summit, 30 life science companies showcase their projects and business cases to investors and potential partners. The event also offer thought-provoking insights from industry leaders and expert investors. The Summit is attended by significant players in the life science ecosystem. The Summit connects innovation and capital, providing small-to-medium ...
Kan vi backa diabetes? - Abarceo Pharma vill utveckla framtidens lösning
Просмотров 2,9 тыс.14 часов назад
Grundaren till bolaget, Claes Wollheim har ägnat sitt yrkesliv åt diabetesforskning. Hör honom berätta om problemen och hur forskningen vill lösa dem. Prenumerera och följ BioStock på: RUclips bit.ly/Biostock LinkedIn: www.linkedin.com/company/biostock Facebook: biostock.se www.biostock.se/ #BioStock #LifeScience #AbarceoPharma Om BioStock BioStock är Skandinaviens ledande digitala...
What will Cereno Scientifics 250 MSEK loan mean for the shareholders?
Просмотров 5 тыс.19 часов назад
Following the company’s positive results from the phase II trial and pivot to fully focus on rare diseases, Cereno Scientific secured a substantial loan. Watch Sten R Sörensen, CEO talk about how this will influence the business and shareholders. 0:09 Introduction 0:30 250 MSEK loan 2:28 Implications for the business 5:40 What does this mean for the shareholders? 6:55 Discussions with potential...
Biosergen discusses positive results in patients with deadly fungal infections
Просмотров 2,9 тыс.19 часов назад
So far, the majority of patients involved in Biosergen's proof-of-concept study for life-threatening fungal infections have been able to leave the hospital. This suggests the potential effect of BSG005 even at low doses. Moreover, the subscription period for the company's TO3 warrants is approaching, which will take place between November 18 and 29. 0:08 Introduction 0:19 Invasive fungal infect...
Oryzon to partner before market entry
Просмотров 3,1 тыс.14 дней назад
Spanish biopharmaceutical company Oryzon develops epigenetic personalized medicines for patients with cancer and CNS disorders. BioStock met with CEO Carlos Buesa at this week’s BIO-Europe conference. He talked about their plans to pursue a phase III trial in Borderline Personality Disorder, and, as for the conference, he eluded to multiple interactions with potential partners.
Cereno Scientific’s CEO on novel therapies for rare diseases
Просмотров 7 тыс.14 дней назад
BioStock met with Cereno Scientifics CEO Sten R. Sörensen at BioEurope. Cereno Scientific is developing novel therapies for rare diseases, with a mission to bring innovative treatments to enhance and extend the lives of patients with high unmet medical needs. In this interview, Sten shares insights on the company’s current projects, their objectives at BioEurope, and the future ahead. 0:08 Intr...
Marknadslansering nästa för Lumitos nya vd
Просмотров 3,4 тыс.14 дней назад
SCIZYS lanseras just nu på forskningsmarknaden. Målet är att erbjuda forskare verktyg för upptäckt av nya, specifika proteinmarkörer och främja preklinisk forskning, vilket på sikt möjliggör mer kvantitativa, precisa diagnoser och förbättrade behandlingsmöjligheter. Sanna Wallenborg är sedan augusti ny vd på Lumito och ger i BioStock Studio sin syn på bolaget, lanseringen och den kapitalanskaff...
ExpreS2ion CEO talking about partnering efforts at BIO-Europe
Просмотров 3 тыс.14 дней назад
Heading towards phase I studies with breast cancer vaccine candidate ES2B-C001, ExpreS2ion Biotech is actively looking for partners. Also, having a well-validated platform, the company recently announced signing a term sheet with Serum Institute of India regarding a malaria vaccine. BioStock talked to CEO Bent U. Frandsen about this at the partnering conference BIO-Europe. 00:00 Opening 00:21 I...
Inhalationsspecialisterna Iconovo tar in kapital
Просмотров 2,9 тыс.14 дней назад
En intranasal fetmabehandling under utveckling, en generisk utmanare till astmaprodukten Symbicort och samtal med potentiella partners står på agendan för Iconovo, som även är aktuella med en företrädesemission om 28,7 miljoner kronor. Se Iconovos vd, Johan Wäborg berätta om den senaste utvecklingen. Prenumerera och följ BioStock på: RUclips bit.ly/Biostock LinkedIn: www.linkedin.com/company/bi...
Aqilion's CEO: "We are driven by dealmaking and scientific data"
Просмотров 2,9 тыс.21 день назад
With four independent programmes in its pipeline, the Swedish biotech Aqilion is positioned for a series of significant upcoming milestones. CEO Sarah Fredriksson joined BioStock’s studio to share updates on the progress of these programmes, key takeaways from the pre-IND meeting with the FDA, and the lasting impact of Aqilion’s previous major deal with Merck - both within the organisation and ...
The temperature of Cereno Scientific after major news
Просмотров 7 тыс.Месяц назад
00:07 Introduction 00:25 Why focus on IPF? 03:35 Regulatory 05:00 Capital markets day 2024 08:36 Large interest 09:41 Partner discussions 10:08 Team efforts 11:30 Next steps for CS014 12:10 What's next for CS1? 13:31 Next up for CS585 Subscribe and follow BioStock on: RUclips bit.ly/Biostock LinkedIn: www.linkedin.com/company/biostock Facebook: biostock.se www.biostock.se/ #BioStoc...
Biosergen advances BSG005 antifungal drug candidate trial
Просмотров 2,9 тыс.Месяц назад
Biosergen is advancing its drug candidate BSG005, designed as a rescue treatment for patients with invasive fungal infections. The company has enrolled the first cohort in their phase Ib Proof-of-Concept trial, with 5 out of a total of 15 patients included so far. Biosergen’s CEO, Tine Olesen, came to BioStock's studio to discuss this milestone, the company’s financing and the next steps ahead....
Chordate Medical's CEO on the company's advancement to final phase of its exit strategy
Просмотров 6 тыс.Месяц назад
Chordate Medical's CEO on the company's advancement to final phase of its exit strategy
100% träffsäkerhet när BibbInstruments testats i patienter - Vad händer nu?
Просмотров 3,1 тыс.Месяц назад
100% träffsäkerhet när BibbInstruments testats i patienter - Vad händer nu?
Sprint Bioscience CEO Johan Emilsson comments on deal potential
Просмотров 3 тыс.Месяц назад
Sprint Bioscience CEO Johan Emilsson comments on deal potential
Cereno Scientific discusses phase IIa results for CS1
Просмотров 3,9 тыс.Месяц назад
Cereno Scientific discusses phase IIa results for CS1
Promimic | INTERVIEW | Investing in Life Science 2024
Просмотров 2,9 тыс.2 месяца назад
Promimic | INTERVIEW | Investing in Life Science 2024
Ziccum | INTERVIEW | Investing in Life Science 2024
Просмотров 2,9 тыс.2 месяца назад
Ziccum | INTERVIEW | Investing in Life Science 2024
Medivir presenterar positiva data på ESMO
Просмотров 3 тыс.2 месяца назад
Medivir presenterar positiva data på ESMO
PainDrainer | INTERVIEW | Investing in Life Science 2024
Просмотров 2,9 тыс.2 месяца назад
PainDrainer | INTERVIEW | Investing in Life Science 2024
Potter Clarkson | INTERVIEW | Investing in Life Science 2024
Просмотров 3 тыс.2 месяца назад
Potter Clarkson | INTERVIEW | Investing in Life Science 2024
Thor Medical | INTERVIEW | Investing in Life Science 2024
Просмотров 2,9 тыс.2 месяца назад
Thor Medical | INTERVIEW | Investing in Life Science 2024
ExpreS2ion Biotech | INTERVIEW | Investing in Life Science 2024
Просмотров 2,9 тыс.2 месяца назад
ExpreS2ion Biotech | INTERVIEW | Investing in Life Science 2024
BioArctic | INTERVIEW | Investing in Life Science 2024
Просмотров 3 тыс.2 месяца назад
BioArctic | INTERVIEW | Investing in Life Science 2024
Abarceo Pharma | INTERVIEW | Investing in Life Science 2024
Просмотров 2,9 тыс.2 месяца назад
Abarceo Pharma | INTERVIEW | Investing in Life Science 2024
Annexin Pharmaceuticals | INTERVIEW | Investing in Life Science 2024
Просмотров 2,9 тыс.2 месяца назад
Annexin Pharmaceuticals | INTERVIEW | Investing in Life Science 2024
100% agree, I just realized that Mario updated his favorite way to tackle ED and it's crazy! Although what he previously talked about was pretty decent, it was difficult to follow, I just go'ogled the latest by Mario Volpstein, it's so much simpler and potent now!
100% agree, I just realized that Mario updated his favorite way to tackle ED and it's crazy! Although what he previously talked about was pretty decent, it was difficult to follow, I just go'ogled the latest by Mario Volpstein, it's so much simpler and potent now!
"Promosm"
Wooooooow beautiful ❤❤❤❤❤
Prenumerera och följ BioStock på: bit.ly/Biostock
Oncoinvent's CEO Anders Månsson presents the company in BioStock's Studio. Subscribe and follow BioStock at: bit.ly/Biostock
Evaxion Biotech's CEO Christian Kanstrup talks AI technology and cancer treatment with BioStock. Subscribe and follow BioStock at: bit.ly/Biostock
🎄!
En lysande pedagog!
BioStock intervjuar professor Tommy Andersson, medgrundare till WntResearch, som ger en uppdatering om bolaget. Prenumerera och följ BioStock på: bit.ly/Biostock
BioStock intervjuar Prostatype Genomics vd Fredrik Persson Följ och prenumerera på BioStock här: bit.ly/Biostock
Prostatype Genomics vd Fredrik Persson presenterar bolaget i BioStocks studio. Följ och prenumerera på BioStock här: bit.ly/Biostock
BioStock intervjuar Genetic Analysis vd Ronny Hermansen om bolagets GA-map-test och emissionen. Prenumerera och följ BioStock på: bit.ly/Biostock
BioStock intervjuar Jens Lindberg, vd för Medivir, om bolagets projekt och emission. Prenumerera och följ: bit.ly/Biostock
Prolight Diagnostics vd Ulf Bladin presenterar bolagets patientnära analyssystem, Psyros, samt företrädesemissionen som ska finansiera vägen fram till kommersialisering. Prenumerera och följ BioStock här: bit.ly/Biostock
BioStock intervjuar Prolight Diagnostics vd Ulf Bladin i samband med företrädesemissionen i december 2023. Prenumerera och följ BioStock här: bit.ly/Biostock
BioStock intervjuar Biovicas vd Anders Rylander om emissionen och bolagets cancertest. Prenumerera och följ BioStock här: bit.ly/Biostock
Biovicas vd Anders Rylander presenterar bolaget i BioStocks studio. Prenumerera och följ BioStock på: bit.ly/Biostock
Vd Ann Gidner presenterar Ziccum i BioStocks studio och berättar om de tre avtal man nu tecknat - ett för varje segment man riktar sig mot. Prenumerera och följ BioStock på: bit.ly/Biostock
👀
Subscribe and follow BioStock at: bit.ly/Biostock
Wow vilket bolag! Sveriges för tillfället mest intressanta biotech!
BioStock intervjuar Sten R. Sörensen, vd för Cereno Scientific, om bolaget justerade tidsplan i fas II-studien, ansökan om compassionate use samt det nyupptagna lånet. Följ och prenumerera på BioStock: bit.ly/Biostock
BioStock interviews Dan Mogren, CEO at CLS, about the company's Q3 and upcoming milestones. Subscribe and follow BioStock at: bit.ly/Biostock
BioStock interviews Torsten Freltoft, CEO of AcouSort, about the company's status and upcoming rights issue. Subscribe and follow BioStock at: bit.ly/Biostock
BioStock interviews Sarah Fredriksson, CEO of Aqilion, about the phase I-results with AQ280. Subscribe and follow BioStock at: bit.ly/Biostock
Cereno Scientific's Capital Markets Day 2023 (August 30) ruclips.net/video/0wAb1CkqCqI/видео.html
BioStock interviews Cyxone's CEO Carl-Magnus Högerkorp and Maarten Kraan, Medical Advisor and member of the company's scientific advisory board. Subscribe and follow BioStock at: bit.ly/Biostock
BioStock intervjuar Elin Trampe, vd för Dicot om vad som hänt under Q3 och status i bolaget. Prenumerera och följ BioStock på: bit.ly/Biostock
Really really important step for Pancreatic cancer
Expert Insight: Optimizing chances of approval: How to achieve effective clinical and regulatory documents, overcome known obstacles and save time & money with Mathilde Thye Kveiborg, Director, Medical Writing, Aixial and Tanja Jensen, Senior Medical Writer, Aixial Subscribe and follow BioStock at: bit.ly/Biostock
Panel: "Business development, licensing & partnering - A Nordic outlook" with Any Balendran, Senior Licensing Director Global Business Development, Novo Nordisk and Tara Heitner, Head of Global Search and Alliance Management, Ferring Pharmaceuticals Subscribe and follow BioStock at: bit.ly/Biostock
Panel: "The evolving landscape of life science investment, funding & alternative sources of capital" with Johan Kördel, Managing Partner, Sound Bioventures and Pieter van der Meijden, Executive Director Life Sciences & Healthcare, Van Lanschot Kempen Subscribe and follow BioStock at: bit.ly/Biostock
Expert Insight: Stock Market Outlook with Carsten Borring, Head of Listings & Capital Markets, NASDAQ Copenhagen Subscribe and follow BioStock at: bit.ly/Biostock
TillaCare's CEO Michael Cohn pitches the company at BioStock Life Science Summit 2023 Subscribe and follow BioStock at: bit.ly/Biostock
CombiGene's CEO Peter Ekolind presents the company at the BioStock Life Science Summit 2023 Subscribe and follow BioStock at: bit.ly/Biostock
Readily Diagnostics' CEO Liza Löf pitches the company at BioStock Life Science Summit 2023 Subscribe and follow BioStock at: bit.ly/Biostock
Cytely's CEO Philip Nordenfelt pitches the company at BioStock Life Science Summit 2023 Subscribe and follow BioStock at: bit.ly/Biostock
Peptonic Medical's CEO Erik Sundquist presents the company at the BioStock Life Science Summit 2023 Subscribe and follow BioStock at: bit.ly/Biostock
IRLAB Therapeutic's CFO Viktor Siewertz presents the company at BioStock Life Science Summit in October 2023. Subscribe and follow BioStock at: bit.ly/Biostock
Authera's CEO Simone Mester pitches the company at BioStock Life Science Summit 2023 Subscribe and follow BioStock at: bit.ly/Biostock
Bionamic's CEO Anders Carlsson pitches the company at BioStock Life Science Summit 2023 Subscribe and follow BioStock at: bit.ly/Biostock
Lipigon's CEO Stefan K Nilsson presents the company at BioStock Life Science Summit in October 2023. Subscribe and follow BioStock at: bit.ly/Biostock
Nygen Analytics' CEO Parashar Dhapola pitches the company at BioStock Life Science Summit 2023 Subscribe and follow BioStock at: bit.ly/Biostock
Cyxone's CEO Carl-Magnus Högerkorp presents the company at BioStock Life Science Summit 2023 Subscribe and follow BioStock at: bit.ly/Biostock
MyCural Therapeutics' CEO Alina Castell pitches the company at BioStock Life Science Summit 2023 Subscribe and follow BioStock at: bit.ly/Biostock
AcouSort's Commercial Director Agnes Michanek presents the company at BioStock Life Science Summit 2023 Subscribe and follow BioStock at: bit.ly/Biostock
Paindrainer's CEO Erik Frick presents the company at BioStock Life Science Summit in October 2023 Subscribe and follow BioStock at: bit.ly/Biostock
SenzaGen's CEO Peter Nählstedt presents the company at BioStock Life Science Summit 2023 Subscribe and follow BioStock at: bit.ly/Biostock
Aqilion's CEO Sarah Fredriksson presents the company at BioStock Life Science Summit 2023 Subscribe and follow BioStock at: bit.ly/Biostock